PL446422A1 - Pharmaceutical composition supporting the immune system before and during upper respiratory tract infection - Google Patents

Pharmaceutical composition supporting the immune system before and during upper respiratory tract infection

Info

Publication number
PL446422A1
PL446422A1 PL446422A PL44642223A PL446422A1 PL 446422 A1 PL446422 A1 PL 446422A1 PL 446422 A PL446422 A PL 446422A PL 44642223 A PL44642223 A PL 44642223A PL 446422 A1 PL446422 A1 PL 446422A1
Authority
PL
Poland
Prior art keywords
respiratory tract
upper respiratory
tract infection
pharmaceutical composition
immune system
Prior art date
Application number
PL446422A
Other languages
Polish (pl)
Inventor
Krzysztof Lemke
Paulina Kowalczyk
Katarzyna Zima
Katarzyna Czapska
Przemysław Żmuda
Natalia Anna Sosnowska
Wojciech Cyplik
Original Assignee
Aronpharma Spółka Z Ograniczoną Odpowiedzialnością
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aronpharma Spółka Z Ograniczoną Odpowiedzialnością filed Critical Aronpharma Spółka Z Ograniczoną Odpowiedzialnością
Priority to PL446422A priority Critical patent/PL446422A1/en
Priority to PCT/PL2024/000055 priority patent/WO2025084939A1/en
Publication of PL446422A1 publication Critical patent/PL446422A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/35—Caprifoliaceae (Honeysuckle family)
    • A61K36/355—Lonicera (honeysuckle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Przedmiotem zgłoszenia jest kompozycja farmaceutyczna wspomagająca układ odpornościowy przed i w trakcie zakażania górnych dróg oddechowych oraz jej zastosowanie do wytwarzania suplementów diety do stosowania w zapobieganiu i leczeniu zakażenia górnych dróg oddechowych.The subject of the application is a pharmaceutical composition supporting the immune system before and during an upper respiratory tract infection and its use for the production of dietary supplements for use in the prevention and treatment of an upper respiratory tract infection.

PL446422A 2023-10-18 2023-10-18 Pharmaceutical composition supporting the immune system before and during upper respiratory tract infection PL446422A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL446422A PL446422A1 (en) 2023-10-18 2023-10-18 Pharmaceutical composition supporting the immune system before and during upper respiratory tract infection
PCT/PL2024/000055 WO2025084939A1 (en) 2023-10-18 2024-10-18 Pharmaceutical composition supporting the immune system before and during upper respiratory tract infections

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL446422A PL446422A1 (en) 2023-10-18 2023-10-18 Pharmaceutical composition supporting the immune system before and during upper respiratory tract infection

Publications (1)

Publication Number Publication Date
PL446422A1 true PL446422A1 (en) 2025-04-22

Family

ID=95448814

Family Applications (1)

Application Number Title Priority Date Filing Date
PL446422A PL446422A1 (en) 2023-10-18 2023-10-18 Pharmaceutical composition supporting the immune system before and during upper respiratory tract infection

Country Status (2)

Country Link
PL (1) PL446422A1 (en)
WO (1) WO2025084939A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL303622A1 (en) * 1994-05-26 1995-11-27 Tadeusz Polanski Immunising preparation
PL439058A1 (en) * 2021-09-29 2023-04-03 Aronpharma Spółka Z Ograniczoną Odpowiedzialnością Antiviral use of a preparation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8337914B2 (en) * 2002-02-27 2012-12-25 Access Business Group International Llc Dietary food supplement containing natural cyclooxygenase inhibitors and methods for inhibiting pain and inflammation
CN106389498A (en) * 2016-11-28 2017-02-15 菏泽普恩药业有限公司 Echinacea purpurea oral liquid and preparation method and application thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL303622A1 (en) * 1994-05-26 1995-11-27 Tadeusz Polanski Immunising preparation
PL439058A1 (en) * 2021-09-29 2023-04-03 Aronpharma Spółka Z Ograniczoną Odpowiedzialnością Antiviral use of a preparation

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BOGDAN-STEFAN NEGREANU-PIRJOL ET AL., "HEALTH BENEFITS OF ANTIOXIDANT BIOACTIVE COMPOUNDS IN THE FRUITS AND LEAVES OF LONICERA CAERULEA L. AND ARONIA MELANOCARPA (MICHX.) ELLIOT" ANTIOXIDANTS 2023, 12(4), 951; HTTPS://DOI.ORG/10.3390/ANTIOX12040951, *
hirondi.com; „Wzmacnianie odporności zdrową dietą. Wszystko o jagodzie kamczackiej na odporność",https://hirondi.com/wzmacnianie-odpornosci-zdrowa-dieta-wszystko-o-jagodzie-kamczackiej-na-odpornosc/, 28 kwietnia 2021 *
POD RED. L. MARKOWSKA, „LEKI POCHODZENIA NATURLANEGO", SPLIT TRADING SP. Z O.O., WARSZAWA, STR.102-103 *

Also Published As

Publication number Publication date
WO2025084939A1 (en) 2025-04-24

Similar Documents

Publication Publication Date Title
PH12022552263A1 (en) Oral compositions of mk2 pathway inhibitor for treatment of immune conditions
MY201603A (en) Combination of dextromethorphan and bupropion for treating depression
RU2015110027A (en) COMPOSITIONS INCLUDING A SINGLE VARIABLE DOMAIN AND CAMOSTAT MESILAT (CM)
RU2010105122A (en) COMPOSITIONS FOR CARE OF THE ORAL CAVITY, PRODUCTS AND METHODS OF APPLICATION
BR9709838A (en) Administration regimen that provides a blood plasma profile of an h +, k + -atpase inhibitor oral pharmaceutical composition and the use of h +, k + -atpase inhibitor and processes to improve the inhibition of gastric acid secretion and the therapeutic effect on treatment of gastrointestinal disorders and to receive an extended plasma profile of an h +, k + -atpase inhibitor
RU2020107732A (en) S1P MODULATOR DOSING SCHEME WITH IMMEDIATE RELEASE
MA34729B1 (en) PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION USEFUL IN THE TREATMENT OF IRRITABLE INTESTINE SYNDROME COMPRISING AN INTESTINAL MOTILITY MODIFIER, AN AGENT PREVENTING THE RETENTION OF GASES AND DIGESTIVE ENZYMES, A METHOD OF PREPARATION OF THE SAME COMPOSITION
PL446422A1 (en) Pharmaceutical composition supporting the immune system before and during upper respiratory tract infection
PL444627A1 (en) Pharmaceutical composition supporting the immune system before and during upper respiratory tract infection
MX2024000239A (en) MEDICINES THAT INCLUDE GLYCOSIDASE INHIBITORS.
RU2015109933A (en) COMPOSITIONS INCLUDING ANTIBODY AND CAMOSTAT MESILATE (CM)
MX2022012693A (en) Composition comprising methylfolate.
MY187270A (en) Renal insufficiency progression inhibitor, prophylactic agent for renal insufficiency and indoxyl sulfate production inhibitor
PL444522A1 (en) Pharmaceutical composition supporting the treatment of diabetes
ZA202308034B (en) Interferon-based cancer treatment method, and pharmaceutical combination
US20170224746A1 (en) Nutritional Support Method For Health Issues
PL437487A1 (en) Pharmaceutical composition and its antiviral application
Lowenthal Peripheral gangrene in infancy and childhood
MX2022012964A (en) Solid oral dosage form comprising pomalidomide.
RU2787175C1 (en) Method for treating patients with a new coronavirus infection covid-19 with high-flow oxygenation
PL425235A1 (en) Application of isoxanthohumol
PH12021550037A1 (en) Pharmaceutical composition in the form of a chewable tablet of diosmin or of a flavonoid moiety
PL425832A1 (en) Genistein and a composition thereof for use in the treatment of Alzheimer's disease
MX2024001230A (en) ORAL CONTRACEPTION WITH PROGESTAGE ONLY.
MX2022012509A (en) NUTRITIONAL FORMULATIONS TO MODULATE CYTOKINES INDUCED BY RESPIRATION.